Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression

被引:24
|
作者
Liu, K
Liu, YX
Hu, ZY
Zou, RY
Chen, YJ
Mu, XM
Ny, T
机构
[1] CHINESE ACAD SCI, INST ZOOL, STATE KEY LAB REPROD BIOL, BEIJING 100080, PEOPLES R CHINA
[2] UMEA UNIV, DEPT MED BIOCHEM & BIOPHYS, S-90187 UMEA, SWEDEN
关键词
corpus luteum; rhesus monkey; urokinase-type plasminogen activator; tissue-type plasminogen activator; plasminogen activator inhibitor type 1;
D O I
10.1016/S0303-7207(97)00152-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Proteolytic activity generated by the plasminogen activator (PA) system has been associated with many biological processes. Using a pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG)-induced rhesus monkey corpus luteum (CL) model, we have studied how urokinase-type plasminogen activator (uPA), tissue-type plasminogen activator (tPA), and plasminogen activator inhibitor type 1 (PAI-I), are temporally expressed in CL of rhesus monkey at the luteotropic and luteolytic periods. Slot blot analysis and in situ hybridization were performed to analyze the expression and distribution of uPA and PAI-I messenger RNA (mRNA). Fibrin overlay was used to detect uPA and tPA activities. We found that uPA is the dominating PA in luteotropic CL in the monkey. Abundant expression of PAI-1 mRNA was detected. The highest expression of uPA and PAI-1 mRNA was observed at the luteotropic period, while their expression decreased approximate to 50% at early luteal regression defined by considerably decreased serum progesterone levels, and remained at very low levels al the late stage of luteal regression. We also observed an increased tPA activity at the time of luteal regression. Moreover, the exogenous tPA could inhibit the progesterone production in cultured luteal cells from 13-day-old monkey CL. We also used LH receptor mRNA expression as a mark for the luteal phases. A highly expressed, evenly distributed LH receptor mRNA was detected in CL during the luteotropic phase, while its expression decreased al day 13 coinciding with the reduction of progesterone production. We conclude that proteolysis mediated by uPA and regulated by PAI-I may play a role in the luteal maintenance, while tPA may participate in the luteal regression in the rhesus monkey. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [1] Identification and Possible Function of Tissue-type and Urokinase-type Plasminogen Activators and Plasminogen Activator Inhibitor in Corpus Luteum of Rhesus Monkey
    刘以训
    冯强
    刘奎
    胡召元
    邹如金
    Science Bulletin, 1994, (20) : 1734 - 1738
  • [2] Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type 1 are coordinately expressed during ovulation in the rhesus monkey
    Liu, YX
    Liu, K
    Feng, Q
    Hu, ZY
    Liu, HZ
    Fu, GQ
    Li, YC
    Zou, RJ
    Ny, T
    ENDOCRINOLOGY, 2004, 145 (04) : 1767 - 1775
  • [3] Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat
    Liu, K
    Brandstrom, A
    Liu, YX
    Ny, T
    Selstam, G
    ENDOCRINOLOGY, 1996, 137 (05) : 2126 - 2132
  • [4] IDENTIFICATION AND POSSIBLE FUNCTION OF TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR IN CORPUS-LUTEUM OF RHESUS-MONKEY
    LIU, YX
    FENG, QA
    LIU, K
    HU, ZY
    ZOU, RJ
    CHINESE SCIENCE BULLETIN, 1994, 39 (20): : 1734 - 1738
  • [5] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [6] ON THE REVERSIBLE INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    LIJNEN, HR
    VANHOEF, B
    COLLEN, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (07) : 4041 - 4044
  • [7] Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta
    Hu, ZY
    Liu, YX
    Liu, K
    Byrne, S
    Ny, T
    Feng, Q
    Ockleford, CD
    JOURNAL OF ANATOMY, 1999, 194 : 183 - 195
  • [8] Expression of urokinase type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer
    Kawasaki, K
    Hayashi, Y
    Wang, Y
    Suzuki, S
    Morita, Y
    Nakamura, T
    Narita, K
    Doe, W
    Itoh, H
    Kuroda, Y
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (09) : 936 - 944
  • [9] Expression and regulation of plasminogen activators, plasminogen activator inhibitor type-1, and steroidogenic acute regulatory protein in the rhesus monkey corpus luteum
    Liu, K
    Feng, Q
    Gao, HJ
    Hu, ZY
    Zou, RJ
    Li, YC
    Liu, YX
    ENDOCRINOLOGY, 2003, 144 (08) : 3611 - 3617
  • [10] GENE INACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    STASSEN, JM
    KIECKENS, L
    VANNUFFELEN, A
    DEMOL, M
    COLLEN, D
    MULLIGAN, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 764 - 764